CoChat

The nocebo effect of drugs

Open access
Planès, Sara, Villier, Céline, Mallaret, Michel · 2016 · Pharmacology Research & Perspectives
Cited by 172

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

While the placebo effect has been studied for a long time, much less is known about its negative counterpart, named the nocebo effect. However, it may be of particular importance because of its impact on the treatment outcomes and public health. We conducted a review on the nocebo effect using PubMed and other databases up to July 2014. The nocebo effect refers by definition to the induction or the worsening of symptoms induced by sham or active therapies. Examples are numerous and concerns both clinical trials and daily practice. The underlying mechanisms are, on one hand, psychological (conditioning and negative expectations) and, on the other hand, neurobiological (role of cholecystokinin, endogenous opioids and dopamine). Nocebo effects can modulate the outcome of a given therapy in a negative way, as do placebo effects in a positive way. The verbal and nonverbal communications of physicians contain numerous unintentional negative suggestions that may trigger a nocebo response. This raises the important issue of how physicians can at the same time obtain informed consent and minimize nocebo‐related risks. Every physician has to deal with this apparent contradiction between primum non nocere and to deliver truthful information about risks. Meticulous identification of patients at risk, information techniques such as positive framing, contextualized informed consent, and even noninformation, is valuable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/prp2.208

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 69

  1. 10.1016/j.pain.2009.07.010 · DOI · Paper page
  2. 10.1007/s10194-007-0360-4 · DOI
  3. 10.7326/0003-4819-130-11-199906010-00016 · DOI · Paper page
  4. 10.1016/j.jams.2012.03.001 · DOI
  5. 10.1016/j.jbspin.2010.08.006 · DOI
  6. 10.1016/S1297-319X(00)00225-6 · DOI
  7. 10.1002/jclp.20131 · DOI · Paper page
  8. 10.1016/S0006-3223(00)00966-5 · DOI
  9. 10.1016/j.jpain.2012.12.011 · DOI
  10. 10.1111/1753-6405.12066 · DOI
  11. 10.3399/bjgp14X677851 · DOI · Paper page
  12. 10.1111/j.2044-8325.1979.tb00444.x · DOI
  13. 10.1098/rstb.2010.0399 · DOI · Paper page
  14. 10.1097/PSY.0b013e3182294a50 · DOI · Paper page
  15. 10.1016/S1474-4422(04)00908-1 · DOI · Paper page
  16. 10.1016/j.mehy.2009.07.023 · DOI
  17. 10.1177/0004867412464717 · DOI · Paper page
  18. 10.1111/j.1745-6592.2004.tb00721.x · doi:10.1111/j.1745-6592.2004.tb00721.x
  19. 10.1001/archinte.163.5.592 · DOI
  20. 10.1136/bmj.313.7072.1624 · DOI · Paper page
  21. 10.1111/j.1365-2125.1995.tb04434.x · DOI · Paper page
  22. 10.2165/11532400-000000000-00000 · DOI
  23. 10.1111/j.1365-2982.2012.01950.x · DOI · Paper page
  24. 10.1016/j.neuron.2008.06.030 · DOI · Paper page
  25. 10.1136/postgradmedj-2012-131730 · DOI · Paper page
  26. 10.1186/2046-4053-1-54 · DOI
  27. 10.1098/rstb.2010.0407 · DOI · Paper page
  28. 10.1007/s10865-005-9040-5 · DOI
  29. 10.1016/j.jpain.2010.02.014 · DOI · Paper page
  30. 10.1159/000189628 · DOI
  31. Hahn RA, 1997, The nocebo phenomenon: scope and foundations. The placebo effect: an interdisciplinary exploration, 56
  32. 10.1006/pmed.1996.0124 · DOI · Paper page
  33. Häuser W, 2012, Nocebo phenomena in medicine: their relevance in everyday clinical practice, Dtsch Ärztebl Int, 109, 459
  34. Häuser W, 2012, Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta‐analysis, Clin Exp Rheumatol, 30, 78
  35. 10.1080/08870449908407311 · DOI · Paper page
  36. 10.1111/j.2044-8287.2012.02071.x · DOI · Paper page
  37. 10.1136/bmj.38726.603310.55 · DOI · Paper page
  38. Kennedy WP, 1961, The nocebo reaction, Med World, 95, 203
  39. 10.1016/j.jpsychores.2008.09.019 · DOI
  40. Liccardi G, 2004, Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions, J Investig Allergol Clin Immunol, 14, 104
  41. 10.1016/j.neubiorev.2008.01.003 · DOI
  42. 10.1016/j.mehy.2011.08.029 · DOI
  43. 10.1007/s11017-011-9179-8 · DOI
  44. 10.1177/0333102410391485 · DOI
  45. 10.1111/j.1743-6109.2007.00563.x · DOI · Paper page
  46. 10.1080/08870440290001494 · DOI · Paper page
  47. 10.1016/S0895-4356(96)00177-1 · DOI · Paper page
  48. 10.1016/j.vaccine.2011.05.045 · DOI
  49. 10.1007/s00415-011-6197-4 · DOI
  50. 10.1037/0022-3514.41.2.213 · DOI
  51. 10.1097/00001756-200208070-00006 · DOI · Paper page
  52. Psaty BM, 1990, The relative risk of incident coronary heart disease associated with recently stopping the use of beta‐blockers, JAMA, 263, 1653, 10.1001/jama.1990.03440120075040 · doi:10.1001/jama.1990.03440120075040 · Paper page
  53. 10.1016/j.genhosppsych.2007.01.010 · DOI
  54. 10.1046/j.1526-4610.2003.03216.x · DOI
  55. 10.1016/j.envres.2008.02.003 · DOI · Paper page
  56. 10.1002/bem.20536 · DOI · Paper page
  57. 10.1016/j.jpainsymman.2012.12.005 · DOI
  58. 10.1001/archgenpsychiatry.2007.34 · DOI · Paper page
  59. 10.1016/j.ijheh.2010.05.001 · DOI
  60. 10.1016/j.homp.2010.02.001 · DOI
  61. Terracciano A, 2014, Are personality traits associated with white‐coat and masked hypertension?, J Hypertens, 1, 16
  62. 10.1213/ANE.0b013e3181cc5727 · DOI · Paper page
  63. 10.1016/j.dld.2010.02.005 · DOI
  64. Voelker R, 1996, Nocebos contribute to host of ills, JAMA, 275, 345, 10.1001/jama.1996.03530290015007 · doi:10.1001/jama.1996.03530290015007
  65. 10.1016/j.pain.2013.04.041 · DOI · Paper page
  66. Weissenfeld J, 2010, The nocebo effect: a reason for patients non‐adherence to generic substitution?, Pharm‐ Int J Pharm Sci, 65, 451
  67. 10.1080/15265161.2011.652798 · DOI · Paper page
  68. 10.1016/j.athoracsur.2012.10.048 · DOI
  69. 10.1016/j.jpsychores.2012.12.002 · DOI · Paper page

Cited by

Metadata

Authors
Planès, S., Villier, C., & Mallaret, M.
Venue
Pharmacology Research & Perspectives
Publisher
Wiley
Published
2016-03-17
Volume
4
Issue
2
Pages
e00208-e00208
ISSN
2052-1707 (ISSN-L)
OpenAlex
W2330425005
Cited by
172
References
17
FWCI
11.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.